Ashley Gallagher is an assistant editor at Pharmacy Times®. She graduated from St. Bonaventure University in 2020 in journalism and mass communications. Previously, she worked as a pharmacy technician for a retail chain.
Study: Smoking Is Worse for the Heart Than Previously Thought
Some function is partially restored once smokers kick the habit, results presented at the European Society of Cardiology Congress 2022 show.
TG Therapeutics’ Ublituximab Shows Reduced Risk of Relapsing Forms of Multiple Sclerosis
Investigational targeted B-cell therapy demonstrates superior efficacy compared with teriflunomide, a commonly prescribed treatment for MS.
Study Shows Rates of Type 2 Diabetes in Children Rose During COVID-19 Pandemic
Analysis from the Johns Hopkins Children’s Center and University of Colorado indicates that cancellation of sports and a switch to virtual learning likely increased this risk.
Amgen Announces Positive Data for ABP959, Biosimilar Candidate to Soliris
Study evaluates efficacy, immunogenicity, safety of the product to eculizumab in patients with paroxysmal nocturnal hemoglobinuria.
FDA Approves Abbott’s Proclaim Plus Spinal Cord Stimulation System
Device provides tailored relief to multiple pain areas and adds more treatment options for evolving conditions.
Study: Incidence of PASC in Pediatric Individuals Is Rare
Analysis shows that myocarditis was the most commonly diagnosed condition associated with pediatric post-acute sequelae of SARS-CoV-2.
78% of Retail Pharmacists Fear Losing Patients When They Choose New Medicare Plans
Additionally, approximately 70% who responded to the EnlivenHealth survey say that one-third or more of their revenue comes from individuals eligible for the government health insurance.
Specialty Spend, Trend Report Shows AbbVie’s Humira Is Top Drug for Overall Cost
As more biosimilars and specialty generics enter the market next year, this could result in a shift in drug spending.
Pfizer, BioNTech Announce Updated COVID-19 Vaccine Efficacy Data for Young Children
Analysis is based on previously reported data collected in March and April 2022, with the FDA granting emergency use authorization for individuals aged 6 months to 4 years on June 17.
Study: Myocarditis Risk Is Significantly Higher After COVID-19 Infection Vs After Vaccine
Analysis includes nearly 43 million individuals aged 13 year and older who received at least 1 dose in England between December 1, 2020, and December 15, 2021.
Study: COVID-19 mRNA Vaccines Decrease Risk of Death for Those With Heart Failure
Results also show that no association with an increased frequency of myocarditis, venous thromboembolism, or worsening HF in these individuals.
Medical Cannabis for Chronic Pain Shows Link to Small Risk of Heart Rhythm Disorders
Danish analysis looks at the relationship between the therapy and cardiovascular adverse effects, particularly arrhythmias.
CVS Health Plans Next Steps to Expand Primary Care by End-of-Year
Executives from CVS Health said they have multiple pathways in achieving a push to establish primary care services, provider enablement, and home health.
Samidorphan/Olanzapine Combination Proves Effective in Treatment of Schizophrenia
Investigators also report that the therapy could mimic the efficacy of olanzapine but cancelled out the medication-induced weight gain, improving symptoms and outcomes.
Study: Ribavirin Forms Mutations of HEV, Causing Relapses, Treatment Failure
A P79S ORF2 variant demonstrates reduced RNA copy numbers released in the supernatant and impaired the production of infectious disease particles, investigators said.
Study Results Show COVID-19 Becomes Infectious When Symptoms are Present
Investigators report that while lateral flow tests do not detect the start of infectiousness well, they can identify individuals who will not infect others and can safely leave isolation.
Illinois Business Partners With Hospital to Reduce Readmissions
Dundee Pharmacy’s compliance packaging encourages patients to stay adherent to their medications.
FDA Accepts NDA for GSK Subsidiary’s Momelotinib for Treatment of Myelofibrosis
The regulatory submission includes data from the MOMENTUM phase 3 clinical trial that met all primary and key second efficacy end points.
Trial Results Suggest Metformin Is Effective at Reducing Odds of Serious COVID-19 Outcomes
University of Minnesota Medical School Analysis shows comparison with fluvoxamine and ivermectin in a double-blinded, placebo-controlled, randomized study.
AHA Statement Outlines Most Common Symptoms of 6 Cardiovascular Disease
The American Heart Association includes 6 conditions and indicates that men’s and women’s experiences may differ.
Study: Abbott’s 2 Blood-Based Biomarkers Can Predict Severity of Traumatic Brain Injury
Investigators used the FDA-approved concussions test i-STAT TBI Plasma and the company’s core laboratory Architect instrument.
FDA Accepts sBLA for Genentech’s Polivy Combination for Diffuse Large B-Cell Lymphoma
The treatment regimen is first in more than 20 years to significantly improve outcomes in individuals with the fast-growing cancer, according to the company.
Study: New Nasal Vaccine Shows Promise for Protection Against COVID-19, HIV
Investigators find that establishing immunity in the mucosal areas establishes a frontline defense against these diseases.
Study: Acupuncture Dynamically Alters Brain Activity for Those With Migraine Without Aura
Analysis is based on functional magnetic resonance imaging to provide insight into the effective connectivity.
AstraZeneca, Daiichi Sankyo’s Enhertu Meets Primary Endpoint of Progression-Free Survival
The drug also meets the key secondary endpoint of improved overall survival for treatment for individuals with HER2 positive unresectable and/or metastatic breast cancer.
Global Generic Drug Market Forecast to Hit $531.8 Billion by 2028
Study results show a compound annual growth rate of 5.2% from $392.4 billion in revenue in 2021.
Study: Children Infected With Mild COVID-19 May Still Develop Long Symptoms
Investigators from University of Texas Health Science Center at Houston analyze data from individuals aged 5 to 18 years enrolled in the Texas CARES survey.
Study Results Show Leisure Activities May Help Lower Dementia Risk by up to 23%
The meta-analysis reviews 38 available studies on the effects of cognitive, physical, and social activities on brain function.
Opioid Prescriptions for US Patients With Cancer, Non-Cancer Pain Falls, Study Results Show
Analysis looks at those with arthritis, chronic pain, headaches, lower back pain, and neuropathic pain between 2012 and 2019.
Study Results Link Neck, Shoulder Pain With Worse Headache, Migraine Symptoms
Investigators aimed to determine how individuals with and without concomitant NSP differ in characteristics and in their perception of treatment responses to analgesics.
2 Clarke Drive Cranbury, NJ 08512